Status:
COMPLETED
Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
to Predict an Unfavorable Evolution of Covid-19 at the Hospital Admission of Patients
Eligibility:
All Genders
18+ years
Brief Summary
The project is a part of the "Protocol for a multicentre study of nosocomial SARS-CoV2 transmission: The NOSO-COR Project" registered in ClinicalTrials (NCT04290780). In the current pandemic context,...
Eligibility Criteria
Inclusion
- Participant must be 18 years or older at the time of signing the informed consent
- Volunteer patients, care givers and healthcare professionals in France and hospitals affiliated with the GABRIEL network. Demographic and clinical data will be collected using case-report forms designed especially for the purpose of the project.
- A nasopharyngeal swab will be collected and tested for SARS-CoV2 by RT-PCR.
- Admission to hospital
Exclusion
- Age lower than 18 years old
- Patients protected by the law
Key Trial Info
Start Date :
November 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2020
Estimated Enrollment :
802 Patients enrolled
Trial Details
Trial ID
NCT04412031
Start Date
November 11 2019
End Date
May 15 2020
Last Update
June 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital E Herriot - Hospices Civils de LYON
Lyon, France, 69437